We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

82 hedge funds and large institutions have $491M invested in Repare Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,276% more call options, than puts

Call options by funds: $1.25M | Put options by funds: $37K

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

38% more capital invested

Capital invested by funds: $356M → $491M (+$135M)

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

15% more funds holding

Funds holding: 71 → 82 (+11)

1.43% more ownership

Funds ownership: 78.27% → 79.69% (+1.4%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
82
Holders Change
+11
Holders Change %
+15.49%
% of All Funds
1.32%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
16
Increased
26
Reduced
21
Closed
5
Calls
$1.25M
Puts
$37K
Net Calls
+$1.21M
Net Calls Change
-$664K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.5M
2
Millennium Management
Millennium Management
New York
+$5.35M
3
Bank of America
Bank of America
North Carolina
+$3.71M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$2.32M
5
BlackRock
BlackRock
New York
+$713K

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$5.98M
2
CA
CHI Advisors
New York
-$4.03M
3
AIM
ARK Investment Management
Florida
-$3.05M
4
HS
HighVista Strategies
Massachusetts
-$2.08M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Trexquant Investment
Connecticut
$1.07M -$106K -7,056 -9%
Goldman Sachs
27
Goldman Sachs
New York
$948K +$226K +15,134 +31%
State Street
28
State Street
Massachusetts
$784K -$2.17K -145 -0.3%
Swiss National Bank
29
Swiss National Bank
Switzerland
$669K +$17.9K +1,200 +3%
Marshall Wace
30
Marshall Wace
United Kingdom
$581K +$591K +39,489 New
HCA
31
Harbor Capital Advisors
Illinois
$509K +$517K +34,572 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$444K +$452K +30,189 New
TCM
33
Tekla Capital Management
Massachusetts
$429K – – –
AG
34
Algert Global
California
$417K – – –
Jane Street
35
Jane Street
New York
$415K +$422K +28,197 New
JF
36
Jump Financial
Illinois
$412K +$147K +9,800 +54%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$396K +$128K +8,567 +47%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$390K +$76.9K +5,142 +24%
Acadian Asset Management
39
Acadian Asset Management
Massachusetts
$384K +$391K +26,165 New
XT
40
XTX Topco
Cayman Islands
$367K +$374K +24,969 New
Northern Trust
41
Northern Trust
Illinois
$338K +$15.6K +1,046 +5%
TD Asset Management
42
TD Asset Management
Ontario, Canada
$335K -$97.3K -6,505 -22%
Blackstone Inc
43
Blackstone Inc
New York
$332K +$51.3K +3,427 +18%
HF
44
HRT Financial
New York
$331K +$337K +22,529 New
N
45
Nuveen
North Carolina
$318K -$2.81K -188 -0.9%
CS
46
Credit Suisse
Switzerland
$313K +$103K +6,873 +48%
FAM
47
Fred Alger Management
New York
$295K -$63.7K -4,256 -18%
CSS
48
Cubist Systematic Strategies
Connecticut
$288K +$293K +19,590 New
AQR Capital Management
49
AQR Capital Management
Connecticut
$262K +$266K +17,807 New
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$251K +$255K +17,034 New
1
2
3 4

RPTX Hedge Fund Activity: Q4 2022 in Review

82 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2022, worth a combined $491M — up 38% from $356M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new RPTX positions and 5 closed out — a net gain of 11 holders — while 26 added to existing stakes and 21 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.5M. The largest seller was Deep Track Capital, cutting an estimated $5.98M.

  • 82 institutional investors held Repare Therapeutics (RPTX) as of Q4 2022, up from 71 in Q3 2022.
  • Funds reported $491M of Repare Therapeutics stock for Q4 2022, up 38% quarter-over-quarter.
  • 16 funds opened new Repare Therapeutics positions in Q4 2022 and 5 closed out, a net change of +11 holders.
  • The largest Repare Therapeutics buyer in Q4 2022 was Fidelity Investments, an estimated $10.5M added.
  • The largest Repare Therapeutics seller in Q4 2022 was Deep Track Capital, an estimated $5.98M sold.

Based on aggregated 13F filings for Q4 2022.